TENDENCY TO CHOOSE FIRST BIOLOGIC AGENT THERAPY OF RHEUMATOID ARTHRITIS IN THE ELDERLY: RESULTS FROM JAPANESE MULTICENTER REGISTRY

被引：1
|
作者：
Watanabe, T. [1 ]
Kojima, T. [1 ]
Takahashi, N. [1 ]
Asai, S. [1 ]
Asai, N. [1 ]
Matsumoto, T. [1 ]
Sobue, Y. [1 ]
Ishiguro, N. [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Orthopaed Surg & Rheumatol, Nagoya, Aichi, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.1679
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0415
引用
收藏
页码：1195 / 1195
页数：1
相关论文
共 50 条
  • [1] Head-to-Head Comparison of the Retention Rate of First Biologics in Elderly Patients with Rheumatoid Arthritis in Japanese Clinical Practice: Results from the Multicenter Biologic Registry
    Hayashi, Masatoshi
    Kanamono, Toshihisa
    Matsubara, Hiroyuki
    Kojima, Toshihisa
    Funahashi, Koji
    Takahashi, Nobunori
    Ishiguro, Naoki
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] Long-Term Outcome Of Infliximab Therapy In Rheumatoid Arthritis Patients: Results From Japanese Multicenter Registry System
    Takahashi, Nobunori
    Kojima, Toshihisa
    Kaneko, Atsushi
    Hirano, Yuji
    Ishiguro, Naoki
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1013 - S1013
  • [3] Long-Term Retention Rate of First Biologics in Patients of Age over 75 Years with Rheumatoid Arthritis in Japanese Clinical Practice: Results from the Multicenter Biologic Registry
    Hayashi, Masatoshi
    Kanamono, Toshihisa
    Matsubara, Hiroyuki
    Kojima, Toshihisa
    Funahashi, Koji
    Takahashi, Nobunori
    Ishiguro, Naoki
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [4] LONG-TERM OUTCOME OF INFLIXIMAB THERAPY IN RHEUMATOID ARTHRITIS PATIENTS -RESULTS FROM JAPANESE MULTICENTER REGISTRY SYSTEM-
    Takahashi, N.
    Kojima, T.
    Funahashi, K.
    Hanabayashi, M.
    Hirabara, S.
    Asai, S.
    Ishiguro, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 477 - 477
  • [5] THE CLINICAL OUTCOME OF ABATACEPT THERAPY IN SINGLE BIOLOGIC FAILURE AND MULTIPLE BIOLOGIC FAILURE WITH RHEUMATOID ARTHRITIS PATIENTS -RESULTS FROM JAPANESE MULTI CENTER REGISTRY SYSTEM-
    Hanabayashi, M.
    Takahashi, N.
    Miyake, H.
    Yokota, Y.
    Kojima, T.
    Ishiguro, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 486 - 487
  • [6] Drug Survival of Biologic Therapy in Elderly Patients With Rheumatoid Arthritis Compared With Nonelderly Patients Results From the Korean College of Rheumatology Biologics Registry
    Jung, Seung Min
    Lee, Sang-Won
    Song, Jason Jungsik
    Park, Sung-Hwan
    Park, Yong-Beom
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (01) : E81 - E88
  • [7] Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry
    Strand, Vibeke
    Miller, Paul
    Williams, Setareh A.
    Saunders, Katherine
    Grant, Shannon
    Kremer, Joel
    RHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 489 - 502
  • [8] Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry
    Vibeke Strand
    Paul Miller
    Setareh A. Williams
    Katherine Saunders
    Shannon Grant
    Joel Kremer
    Rheumatology and Therapy, 2017, 4 : 489 - 502
  • [9] BIOLOGIC THERAPY IN RHEUMATOID ARTHRITIS: RESULTS FROM THE ROMANIAN REGISTRY OF RHEUMATIC DISEASES ONE YEAR AFTER INITIATION
    Codreanu, Catalin
    Mogosan, Corina
    Ionescu, Ruxandra
    Ancuta, Ioan
    Opris, Daniela
    FARMACIA, 2014, 62 (06) : 1089 - 1096
  • [10] WHICH BIOLOGIC AGENT IS MOST SUITABLE FOR AN EXTENDED-INTERVAL TREATMENT FOR RHEUMATOID ARTHRITIS ? RESULTS FROM A MULTICENTER STUDY
    Katayama, K.
    Matsuno, H.
    Matsubara, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 943 - 944
12345